Skip to main content
. 2019 Jul 5;27(9):1558–1567. doi: 10.1016/j.ymthe.2019.06.013

Figure 6.

Figure 6

CGX1321 in Liposome Formulation Enhances CGX1321 Tolerance and Decreased the Toxicity to Mice

H&E (A) and Alcian blue (B) staining of the vehicle and treated tumor samples. (C) Tumor growth was plotted by mean with SEM (n = 8). Tumor samples were from GA007 PDX mice, which were treated with 10 mL/kg liposome blank, 10 mg/kg CGX1321 in D5W, p.o., q.d., or 10 mg/kg CGX1321 in liposome, i.v., q.o.d., for 14 days. (D) Bodyweight changes were calculated before and after CGX1321 in D5W or liposome formulation treatments for 14 days (n = 8), ***p < 0.0001.